Tantia Constructions Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 30, 2025, 11:44 am

Quick Insight

Tantia Constructions Ltd's current market price of 25.8 with a P/E ratio of 4.08 indicates potential undervaluation in the construction and contracting sector. The company's robust Return on Equity (ROE) at 35.6% and Return on Capital Employed (ROCE) at 17.2% reflect efficient capital utilization. However, the low Operating Profit Margin (OPM) of 6.39% may warrant attention to improve operational efficiency. With a healthy Interest Coverage Ratio (ICR) of 50.78x and a Price-to-Book Value (P/BV) of 1.59x, Tantia Constructions Ltd appears financially stable despite a relatively high Current Ratio of 470 days. Investors should monitor the company's ability to manage its substantial borrowings of ₹339Cr to ensure sustainable growth in shareholder value.

Competitors of Tantia Constructions Ltd

All Competitor Stocks of Tantia Constructions Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:40 am

Below is a detailed analysis of the quarterly data for Tantia Constructions Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 11.74 Cr.. The value appears to be declining and may need further review. It has decreased from 49.73 Cr. (Mar 2025) to 11.74 Cr., marking a decrease of 37.99 Cr..
• For Expenses, as of Jun 2025, the value is 10.99 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 26.77 Cr. (Mar 2025) to 10.99 Cr., marking a decrease of 15.78 Cr..
• For Operating Profit, as of Jun 2025, the value is 0.75 Cr.. The value appears to be declining and may need further review. It has decreased from 22.96 Cr. (Mar 2025) to 0.75 Cr., marking a decrease of 22.21 Cr..
• For OPM %, as of Jun 2025, the value is 6.39%. The value appears to be declining and may need further review. It has decreased from 46.17% (Mar 2025) to 6.39%, marking a decrease of 39.78%.
• For Other Income, as of Jun 2025, the value is 0.91 Cr.. The value appears to be declining and may need further review. It has decreased from 33.94 Cr. (Mar 2025) to 0.91 Cr., marking a decrease of 33.03 Cr..
• For Interest, as of Jun 2025, the value is 0.15 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.76 Cr. (Mar 2025) to 0.15 Cr., marking a decrease of 0.61 Cr..
• For Depreciation, as of Jun 2025, the value is 0.41 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.39 Cr. (Mar 2025) to 0.41 Cr., marking an increase of 0.02 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.10 Cr.. The value appears to be declining and may need further review. It has decreased from 55.75 Cr. (Mar 2025) to 1.10 Cr., marking a decrease of 54.65 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 5.20% (Mar 2025) to 0.00%, marking a decrease of 5.20%.
• For Net Profit, as of Jun 2025, the value is 1.10 Cr.. The value appears to be declining and may need further review. It has decreased from 52.85 Cr. (Mar 2025) to 1.10 Cr., marking a decrease of 51.75 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.07. The value appears to be declining and may need further review. It has decreased from 3.41 (Mar 2025) to 0.07, marking a decrease of 3.34.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 4, 2025, 10:35 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 4, 2025, 10:35 am

Below is a detailed analysis of the balance sheet data for Tantia Constructions Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 16.00 Cr..
• For Reserves, as of Mar 2025, the value is 288.00 Cr.. The value appears strong and on an upward trend. It has increased from 232.00 Cr. (Mar 2024) to 288.00 Cr., marking an increase of 56.00 Cr..
• For Borrowings, as of Mar 2025, the value is 339.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 334.00 Cr. (Mar 2024) to 339.00 Cr., marking an increase of 5.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 81.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 69.00 Cr. (Mar 2024) to 81.00 Cr., marking an increase of 12.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 724.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 650.00 Cr. (Mar 2024) to 724.00 Cr., marking an increase of 74.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2024) to 8.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 422.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 422.00 Cr..
• For Investments, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 289.00 Cr.. The value appears strong and on an upward trend. It has increased from 214.00 Cr. (Mar 2024) to 289.00 Cr., marking an increase of 75.00 Cr..
• For Total Assets, as of Mar 2025, the value is 724.00 Cr.. The value appears strong and on an upward trend. It has increased from 650.00 Cr. (Mar 2024) to 724.00 Cr., marking an increase of 74.00 Cr..

However, the Borrowings (339.00 Cr.) are higher than the Reserves (288.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Tantia Constructions Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.62. This value is below the healthy minimum of 5. It has decreased from 10.79 (Mar 24) to 3.62, marking a decrease of 7.17.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.62. This value is below the healthy minimum of 5. It has decreased from 10.79 (Mar 24) to 3.62, marking a decrease of 7.17.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.73. This value is within the healthy range. It has increased from -1.28 (Mar 24) to 3.73, marking an increase of 5.01.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 19.59. It has increased from 15.97 (Mar 24) to 19.59, marking an increase of 3.62.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 19.59. It has increased from 15.97 (Mar 24) to 19.59, marking an increase of 3.62.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 5.47. It has increased from 3.42 (Mar 24) to 5.47, marking an increase of 2.05.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.91. This value is within the healthy range. It has increased from -0.29 (Mar 24) to 6.91, marking an increase of 7.20.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.79. This value is within the healthy range. It has increased from -0.45 (Mar 24) to 6.79, marking an increase of 7.24.
• For PBT / Share (Rs.), as of Mar 25, the value is 3.80. This value is within the healthy range. It has increased from -1.17 (Mar 24) to 3.80, marking an increase of 4.97.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 3.61. This value is within the healthy range. It has increased from -1.43 (Mar 24) to 3.61, marking an increase of 5.04.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.61. This value is within the healthy range. It has increased from -1.43 (Mar 24) to 3.61, marking an increase of 5.04.
• For PBDIT Margin (%), as of Mar 25, the value is 126.26. This value is within the healthy range. It has increased from -8.74 (Mar 24) to 126.26, marking an increase of 135.00.
• For PBIT Margin (%), as of Mar 25, the value is 124.11. This value exceeds the healthy maximum of 20. It has increased from -13.21 (Mar 24) to 124.11, marking an increase of 137.32.
• For PBT Margin (%), as of Mar 25, the value is 69.38. This value is within the healthy range. It has increased from -34.23 (Mar 24) to 69.38, marking an increase of 103.61.
• For Net Profit Margin (%), as of Mar 25, the value is 65.96. This value exceeds the healthy maximum of 10. It has increased from -41.88 (Mar 24) to 65.96, marking an increase of 107.84.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 65.96. This value exceeds the healthy maximum of 20. It has increased from -41.88 (Mar 24) to 65.96, marking an increase of 107.84.
• For Return on Networth / Equity (%), as of Mar 25, the value is 18.43. This value is within the healthy range. It has increased from -8.97 (Mar 24) to 18.43, marking an increase of 27.40.
• For Return on Capital Employeed (%), as of Mar 25, the value is 30.35. This value is within the healthy range. It has increased from -2.38 (Mar 24) to 30.35, marking an increase of 32.73.
• For Return On Assets (%), as of Mar 25, the value is 7.73. This value is within the healthy range. It has increased from -3.41 (Mar 24) to 7.73, marking an increase of 11.14.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 0.2. It has decreased from 0.15 (Mar 24) to 0.11, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.12. This value exceeds the healthy maximum of 1. It has decreased from 1.35 (Mar 24) to 1.12, marking a decrease of 0.23.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.12. It has increased from 0.07 (Mar 24) to 0.12, marking an increase of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1.5. It has increased from 0.36 (Mar 24) to 0.50, marking an increase of 0.14.
• For Quick Ratio (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has increased from 0.27 (Mar 24) to 0.44, marking an increase of 0.17.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.36. This value is below the healthy minimum of 4. It has decreased from 0.41 (Mar 24) to 0.36, marking a decrease of 0.05.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 50.78. This value is within the healthy range. It has increased from -3.14 (Mar 24) to 50.78, marking an increase of 53.92.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 48.54. This value is within the healthy range. It has increased from -7.48 (Mar 24) to 48.54, marking an increase of 56.02.
• For Enterprise Value (Cr.), as of Mar 25, the value is 814.80. It has decreased from 856.55 (Mar 24) to 814.80, marking a decrease of 41.75.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.60. This value exceeds the healthy maximum of 3. It has decreased from 16.15 (Mar 24) to 9.60, marking a decrease of 6.55.
• For EV / EBITDA (X), as of Mar 25, the value is 7.60. This value is within the healthy range. It has increased from -184.60 (Mar 24) to 7.60, marking an increase of 192.20.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.70. This value exceeds the healthy maximum of 3. It has decreased from 10.01 (Mar 24) to 5.70, marking a decrease of 4.31.
• For Price / BV (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has decreased from 2.14 (Mar 24) to 1.59, marking a decrease of 0.55.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.70. This value exceeds the healthy maximum of 3. It has decreased from 10.01 (Mar 24) to 5.70, marking a decrease of 4.31.
• For EarningsYield, as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has increased from -0.04 (Mar 24) to 0.11, marking an increase of 0.15.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness